Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies
Completed · Phase 1/Phase 2
Conditions studied: Hematologic Malignancies, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Chronic Myelogenous Leukemia, Acute Graft-versus-host Disease
In brief
This study is a Phase 1, non-randomized, open-label/Phase 2 randomized, blinded study of ProTmune (ex vivo programmed mobilized peripheral blood cells) versus non-programmed mobilized peripheral blood cells for allogeneic hematopoietic cell transplantation (HCT) in adult subjects aged 18 years and older with hematologic malignancies. A total of 88 study subjects were treated in the trial at approximately 15 centers in the US.
Key facts
- Study ID
- NCT02743351
- Run by
- Fate Therapeutics
- People needed
- 96
- Starts
- 2016-12-20
- Expected to finish
- 2021-11-05
- Last updated by the study team
- 2023-02-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Alabama — Birmingham, Alabama, United States
- City of Hope — Duarte, California, United States
- University of California, San Diego (UCSD) Moores Cancer Center — San Diego, California, United States
- University of Chicago — Chicago, Illinois, United States
- Indiana Blood and Marrow Transplant — Indianapolis, Indiana, United States
- Dana Farber Cancer Institute — Boston, Massachusetts, United States
- Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States
- Weill Cornell Medicine — New York, New York, United States
- Jewish Hospital — Cincinnati, Ohio, United States
- The Ohio State University — Columbus, Ohio, United States
- Oregon Health & Science University — Portland, Oregon, United States
- Sarah Cannon Research Institute — Nashville, Tennessee, United States
- Texas Transplant Institute — San Antonio, Texas, United States
- Huntsman Cancer Institute (University of Utah) — Salt Lake City, Utah, United States
- Virginia Commonwealth University — Richmond, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.